Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  FUREN Group Pharmaceutical Co Ltd    600781   CNE000000NM4

FUREN GROUP PHARMACEUTICAL CO LTD

(600781)
  Report  
End-of-day quote. End-of-day quote SHANGHAI STOCK EXCHANGE - 05/23
13.04 CNY   -1.88%
 SummaryQuotesChartsCalendarCompanyFinancialsRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
05/17/2019 05/20/2019 05/21/2019 05/22/2019 05/23/2019 Date
13.42(c) 13.17(c) 13.45(c) 13.29(c) 13.04 Last
6 262 600 3 884 580 4 219 967 3 283 746 2 789 400 Volume
-5.23% -1.86% +2.13% -1.19% -1.88% Change
More quotes
Company
FUREN Group Pharmaceutical Co., Ltd., formerly Furen Pharmaceutical Group Industry Co., Ltd., is a China-based company principally engaged in the manufacturing, wholesale and retail of pharmaceuticals. The Company's principal business is the manufacture of proprietary Chinese medicines, including... 
Sector
Pharmaceuticals
Calendar
08/28Earnings Release
More about the company
Latest news on FUREN GROUP PHARMACEUTICAL

- No features available -

More news
Sector news : Pharmaceuticals - NEC
01:09pGLAXOSMITHKLINE : GSK brings back bonuses for some sales reps
RE
12:59pGLAXOSMITHKLINE : GSK's shingles vaccine approved for use in China in adults age..
RE
11:31aNOVARTIS : CEO says data quality, lagging innovation crimp China M&A
RE
11:30aNOVARTIS : CEO says data quality, lagging innovation crimp China M&A
RE
10:31aGLAXOSMITHKLINE : GSK to change incentives for sales representatives
RE
More sector news : Pharmaceuticals - NEC
Chart FUREN GROUP PHARMACEUTICAL CO LTD
Duration : Period :
FUREN Group Pharmaceutical Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FUREN GROUP PHARMACEUTICAL
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
EPS Revisions
Managers
NameTitle
Wen Chen Zhu Chairman & General Manager
Wen Yu Zhu Chairman-Supervisory Board
Xue Jiu Zhu Chief Financial Officer
Cheng Gong Zhu Vice Chairman
Wen Liang Zhu Director & Deputy General Manager
Sector and Competitors
1st jan.Capitalization (M$)
FUREN GROUP PHARMACEUTICAL CO LTD5.06%1 206
JOHNSON & JOHNSON7.03%368 416
PFIZER-4.54%233 461
ROCHE HOLDING LTD.9.84%228 186
NOVARTIS13.31%210 460
MERCK AND COMPANY5.98%208 495